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Abstract 
Automation is universal in today's society, from operating equipment such as machinery, in factory 
processes, to self-parking automobile systems. While these examples show the efficiency and 
effectiveness of automated mechanical processes, automated procedures that support the chemical 
risk assessment process are still in their infancy. Future human safety assessments will rely 
increasingly on the use of automated models, such as physiologically based kinetic (PBK) and 
dynamic models and the virtual cell based assay (VCBA). These biologically-based models will be 
coupled with chemistry-based prediction models that also automate the generation of key input 
parameters such as physicochemical properties. The development of automated software tools is an 
important step in harmonising and expediting the chemical safety assessment process. In this study, 
we illustrate how the KNIME Analytics Platform can be used to provide a user-friendly graphical 
interface for these biokinetic models, such as PBK models and VCBA, which simulates the fate of 
chemicals in vivo within the body and in vitro test systems respectively. 
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Introduction 
Future human safety assessments will rely increasingly on the use of multi-scale models, such as 
Physiologically-Based Kinetic / Dynamic (PBK/D) models and Virtual Cell Based Assay (VCBA) 
models to calculate internal concentrations and perform extrapolations such as in vitro to in vivo 
extrapolation (IVIVE). These biologically-based models will be coupled with chemistry-based 
prediction models that also automate the generation of key input parameters such as physicochemical 
properties. The implementation and integration of such models within an automated and user-friendly 
computational platform will make them more easily accessible and applicable to support the chemical 
risk assessment process.  
The development of computational tools and predictive models to support the safety assessment of 
chemicals, in particular cosmetics-related substances, was the goal of the EU COSMOS project 
(http://www.cosmostox.eu/), with the aim to making the models publicly available in a user-friendly 
format. The models included prediction models for specific effects based on structure-activity 
relationships, absorption models to support extrapolation from oral to dermal exposure, especially 
relevant for cosmetics substances, as well as the biokinetics models described here. 
The VCBA can be used to support (i) the design of in vitro High Throughput Screening (HTS) 
experiments; (ii) hazard identification (based on acute systemic toxicity); and (iii) QIVIVE approaches 
to help risk assessment decision making. The VCBA is a mathematical model that was built using the 
R language and was applied to study the toxicological effects of chemicals on cells (Zaldívar et al., 
2010, 2011, 2012, 2016). The model consists of differential equations whose solution allows the 
calculation over time of the dissolved concentration of a chemical in a well plate as well as the internal 
concentration in the cells. The VCBA model (Zaldivar et al., 2016) consists of four inter connected 
models, describing (i) a fate and transport of the time-dependent chemical concentration in the 
medium and in the headspace; (ii) partitioning in the cell, assuming an instant partitioning of the 
chemical to water, lipid, and protein within the cell after uptake; (iii) the four stage of cell cycle, (cell 
growth and division); and (iv) cell dynamics: toxicity and effect. In addition the model takes into 
account the experimental conditions (i.e. well shape).  
Similarly, PBK models mimic the distribution of a chemical in the body. These models represent the 
body as interconnected compartments, describing the organs, and with inter-compartment fluxes 
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described by differential equations. The level of complexity of these models depends on the intended 
application and available biological information: by predicting concentration and time profile curves 
(Cmax and AUC), these models can support the submission of drugs to be evaluated by medical 
agencies; they can be used to support chemical risk assessments; as well as informing experimental 
design. In the last decade there has been an increase in development of PBK models, because of 
more accurate simulations of in vivo adsorption, distribution, metabolism and excretion processes 
compared to the classical PK models (Gajewska et al., 2015). For example, 11 chemical specific PBK 
models were developed within the EU COSMOS project (Bois et al, 2016; Teng et al., 2015; 
Gajewska 2014, 2015). Furthermore, an initiative to develop a database of existing PBK models is 
currently ongoing at US EPA (Lu et al. 2016). This database provides useful information on how the 
models were built. Furthermore, several commercial tools are available to program (Matlab, R 
language, Berkeley Madonna, etc.), build and use (SimCyp, gastroplus/ADMET, PkSim, ACSL/X, 
etc.) as well as tools that can be used without a commercial licence: MERLIN EXPO (Ciffroy et al., 
2016; Suciu et al., 2016), MEgen and Rvis, (Loizou, G, and Hogg A., 2011) COSMOS (Bois et al., 
2016). 
The coupling of a PBK model, describing the kinetics, and the VCBA, describing the dynamic effects 
(that can be adverse or beneficial) will give rise to a model that can be applied to extrapolate from an 
in vitro concentration to the external dose of exposure. In Vitro to In Vivo Extrapolation (IVIVE) is a 
useful approach in the prioritization of chemical testing in chemical risk assessment (Kramer et al., 
2015; Allen et al., in preparation). To better exploit the utility of IVIVE, there is a need to develop 
automated tools that perform the extrapolation in a simple and fast way.  
As described above, these models consist of many parameters that are feeding the equations, 
physicochemical, cell line and experimental characteristics. The use of such models entails a need to 
manage a large and diverse set of data, from parameters to in vitro dose response curves analysis. 
The best way is to implement good data management practice and develop automated workflows. 
The KNIME Analytics Platform (Berthold et. al, 2009; http://www.knime.org/) is a free, user-friendly 
graphical workbench for data analytics including data management, data transformation, 
investigation, visualization and reporting. The COSMOS biokinetic models have been implemented in 
two KNIME versions, so that they can be executed either locally on a desktop computer (following 
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installation of the KNIME Analytics Platform) or directly online from a web browser using a KNIME 
WebPortal (http://knimewebportal.cosmostox.eu). With a view to promoting end-user acceptance of 
these KNIME-based workflows, bespoke documentation is available (see 
http://www.cosmostox.eu/what/webtutorials/). Figure 1 describes schematically how the workflows for 
the VCBA, PBK models, and IVIVE approach were set up, with an input zone indicating which input 
parameters are needed to run the simulation per type of workflow, the core model and output zone, 
with description of which output the model provides per workflow. The optimal interface should allow 
untrained users to use these workflows in an intuitive way. In this study, we illustrate how the KNIME 
workflows for the PBK model, the VCBA, and IVIVE approach were built and how they can be used as 
a user-friendly graphical interface to predict different model simulations and outcomes. The 
development of automated software tools is an important step in harmonising and expediting the 
chemical safety assessment process. 
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Figure 1. A. Schematic representation of the general setup of the automated VCBA KNIME workflow 
for the kinetic models developed; this set up is based on three zones: input, model (core zone where 
the code is kept), and output. B. Schematic representation of the general setup of the automated 
Physiologically Based Kinetic model; C. Schematic representation of the general setup of the 
automated in vitro to in vivo extrapolation approach .   
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Methodology 
We implemented the PBK models, VCBA, and the IVIVE approaches as open source platforms using 
KNIME (version 3.0) and R programs (which both are freely available). The KNIME Analytics Platform 
is a user-friendly graphical workbench for data analysis (http://www.knime.org/) and R is a language 
and environment for statistical computing and graphics (http://www.r-project.org/). KNIME consists of 
a series of pieces of program code called nodes that can be connected in such way that the input of 
one node is the output of the previous one. Each node has a dialog in which the user can configure 
the operation of the node. 
Implementation of the Virtual Cell-Based Assay model in KNIME 
This VCBA KNIME implementation includes three important features:  
 Several operational modes: single exposure, repeated exposure, parameter optimization and 
optimization check.  These are further described below. 
 Three separate zones: input, model, and output. 
 Can be run on the KNIME Server (online) or in the KNIME Analytics Platform as locally 
installed version in a desktop computer. 
In the following, we will introduce and explain the most significant nodes that build up the KNIME 
workflow as represented in Figure 2.  
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Figure 2: KNIME workflow of the Virtual Cell Based Assay Model, divided into three zones: Input 
Zone, Model Zone (where the model script is kept and executed), and the Output Zone. For purposes 
of figure presentation the nodes that where not relevant for running the workflow, were collapsed into 
metanodes. 
 
The automated VCBA KNIME workflow can be run in several modes. The Single Exposure mode of 
operation describes the process for a single exposure of the chemical to the cells. The present 
version can be run for several chemical concentrations. From one run to the next all parameters are 
reset to initial values except the initial chemical concentration. The other mode is Repeated Exposure, 
which describes the effect of several cell exposures of a single chemical concentration. From one run 
to the next, the last values of chemical concentration inside the cell and the number of cells are 
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considered as the initial values for the next exposure, whereas the initial chemical concentration 
remains the same. The toxicological effect of cell exposure to chemicals in the VCBA is described by 
two parameters: the No Effect Concentration (NEC) and kt (where t is exposure time, and k is a 
characteristic of the chemical and cell line). The values of NEC and kt are then optimised by 
comparing the simulated (Viabilitysim) and experimental (Viabilityexp) cell viabilities and by minimizing 
the following error function: 
 


exp
1
2
exp
on
i
simViabilityViabilityerror 1 
The optimization check gives us a graphical interface which is used to validate the values of NEC and 
kt. Paired values of chemical concentration and viability are introduced in a List Box Input node, while 
the initial values of NEC and kt are in two Double Input nodes. The Optimization Check functionality 
was separated from the Parameter Optimization to enable available values of NEC and kt to be 
entered directly without the need to run the time-consuming Parameter Optimization Mode every time. 
The building blocks of the three zones are explained in more detail in the following section. 
1) The Input Zone is used to feed the model with the necessary input data. It consists of a series of
nodes where files are uploaded to input and select data for chemicals and cell lines: 
 Data related to the cell line such as duration, mortality, mass, volume in each cell stage, cell
duration (see Zaldivar et al., 2016).
 Data related to the organic compound. By uploading a file containing the information on the
parameters for the organic compound to be run. The chemical data needed to run simulation
are chemical name (Chem name), CAS number (cas), logKow, molar volume, atomic
diffusion, MW, water degradation, air degradation, and Henry's law constant (see Zaldivar et
al., 2016).
 Toxicological data: the NEC and kt for each chemical and cell line (see Zaldivar et al., 2016).
 Experimental set-up data: The Tissue Culture (TC) plates node is a table that contains
information on the technical specifications of the plates in the High Throughput Screening
(HTS) as well as non-HTS experiments. These data are used to compute properties related to
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fate and transport, such as chemical binding to plastic or evaporation across the air-water 
interface (see Zaldivar et al., 2016).  
 Data to be simulated (e.g. range of chemical concentration inside the cells, time of 
simulation). 
For data to be simulated, the data introduced depends of the mode of operation: 
 Single Exposure: Several chemical concentrations to be simulated are introduced in the List 
Box Input node separated by “,”.  
 Repeated Exposure: Unique chemical conc. in a Double Input node, the interval between 
doses and the number of repeated exposures in an Integer Input node.  
 Parameter Optimization: Is used to optimize values related with toxicological data: NEC and 
kt. In a List Box Input node pairs of chemical concentration and viability are introduced and in 
two Double Input nodes, the initial values of NEC and kt. In the case of single and repeated 
exposure the values of NEC and kt are in the toxicological data table.  
 
To run the model, the following additional information is needed: Total time (Integer Input node), Initial 
number of cells (Integer Input node), Assay Volume (Double Input node). 
2) The Model Zone contains the mathematical script (Figure 3) and executes the simulations. The 
input parameters are provided to the R Snippet node through the variable knime.in. We have written 
the differential equations describing the VCBA in R language and have integrated them into KNIME 
through its R integration. In this way the model is accessible to the user without the need to modify it. 
The differential equations describing the mass balance resulting from fate, cell dynamics and 
toxicodynamics are solved by the DeSolve R package (see Zaldivar et al., 2016, Paini et al., 2016).). 
The VCBA is an integrated mathematical model that can be run in several operational modes (which 
can be Single Exposure simulation, Repeated Exposure simulation, Parameter Optimization, 
Optimization Check). To perform this, we create a function called coreModel inside the R snippet 
node. This function is an R function that has five input parameters: chemical concentration in the 
medium, chemical concentration inside the cell, the number of cells, NEC and kt. The coreModel 
function is called several times depending on the operation mode. In the case of single exposure, 
coreModel is called one time for a single chemical concentration to be simulated whereas the rest of 
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parameters remain constant. In the case of repeated exposure, there is a single chemical 
concentration exposure and the chemical concentration inside the cell and the resulting number of 
cells is taken into consideration for the next exposure. In the Parameter Optimization mode, the core 
model calculates the simulated viability for each chemical concentration based on the initial values of 
NEC and kt given in the two Double Input nodes. The results of the R Snippet node are output using 
the knime.out variable. 
 
Figure 3. Detail of R script code of the VCBA model (R snippet node). 
 
3) Output Zone: The output from the R Snippet node is sent to several output nodes to provide and 
visualize the results. For tabulated data results, KNIME offers a variety of nodes that can store data. 
For graphical results, R Table View node is a KNIME node that generates graphics using R code. To 
show the results in a KNIME Server a series of additional nodes are needed. For graphics, each R 
Table View node is associated with an image output node. For small tables, a Textarea Output node 
can be used inserting the flow variable values into a structured html table. Furthermore, two report 
nodes provide a downloadable report of the results. 
 
 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
12 
Implementation of the Physiologically Based Kinetic models in KNIME 
The PBK model KNIME workflow is set up in a similar way as the VCBA one, with an Input, Model 
and Output zone. The input parameters, physiological data and physicochemical parameters are 
stored in a file and upload in the node. The range of time and doses (initial and final) must be 
provided. The R code representing the PBK model is stored in the model zone of the workflow and 
the output is reported as graphical representation of concentration time profile curves per target organ 
and as a table to be able to extract AUC and Cmax values (Figure SM1). To describe different 
exposure we used the same workflow with two different R codes describing oral and dermal 
exposures, respectively (Figure SM2). 
Implementation of the extrapolation from in vitro to in vivo in KNIME 
The KNIME workflow built for extrapolating from an in vitro concentration to an in vivo exposure doses 
(IVIVE KNIME workflow) was built in three parts, input, model, output zone (Figure SM5). The input 
parameters are the same as reported for the PBK model (physiological and physicochemical 
properties) with addition of the cell model (thus cell type properties) and toxicity effect (No effect 
concentration, NEC, and Killing rate, Kr), so to be able to simulate dynamic effect (i.e. viability). The 
present workflow included three R codes, the first one representing the PBK model, the second one 
built to allow extrapolation of the number of DNA adducts formed and the third one to allow the 
extrapolation from a range of concentrations simulated to a range of exposure doses and to link to the 
effect based on the output of the first R code (PBK model). The extrapolation was done using the 
dose response curve obtained by the PBK model simulation. So far these workflows are chemical 
specific, and only 3 workflows were built for estragole, caffeine (Gajewska et al., 2015), and coumarin. 
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Implementation as COSMOS KNIME WebPortal version 
The COSMOS KNIME WebPortal is freely accessible (http://knimewebportal.cosmostox.eu) and is 
supported by COSMOS Space (http://cosmosspace.cosmostox.eu), a facility to share predictive 
toxicology resources. The COSMOS Space provides free registration to login to the COSMOS KNIME 
WebPortal (log-in credentials are the same as for COSMOS Space) and hosts the workflow 
documentation as well as user guidance. Web tutorials for the different workflows are available from 
the COSMOS project website (http://www.cosmostox.eu/what/webtutorials/).  
The PBK models, VCBA and the IVIVE approach workflows have been implemented additionally as 
WebPortal version. This allows execution of workflows through a web interface from any recent web 
browser by access to the KNIME Server, without installation of the software locally and without 
knowledge of the KNIME workflows as such. The WebPortal allows for a step-by-step execution. 
Each step asks for user input, such as files or model parameters, potentially also dependent on 
previous inputs. After all inputs have been provided, the workflow is executed and the results can be 
downloaded as files and/or graphical reports are generated as summaries.   
The VCBA KNIME nodes for input parameters and output data are the same in the desktop version as 
in the server version. Since the Parameter Optimization mode requires a long time to optimize the 
parameters, this can be performed only in the desktop version. 
The first screen in the COSMOS KNIME WebPortal is a textual introduction to the model (Figure 4). 
Clicking on start a new page will appear with blank boxes where parameters can be filled in by the 
user. To create this form a series of KNIME nodes are used: i) Integer Input node; ii) Double Input 
node and so on, as described previously for the input zone.  
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
14 
Figure 4. Description of the VCBA model in the COSMOS KNIME WebPortal. 
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Results 
Application of the automated tools developed 
Now that the VCBA automated tool is built and ready to use (either locally or from the WebPortal) we 
will show some concrete simulation results using two chemicals, acetaminophen and caffeine, as 
illustrative examples. The first version of the model (2015) works in single dose mode for the following 
compounds: acetaminophen, verapamil hydrochloride, acetylsalicylic acid, maprotiline, cycloheximide, 
sodium lauryl sulphate, tert-butylhydroperoxide, valproic acid, rifampin, thioridazine hydrochloride, 
caffeine, colchicine, acrylamide, diphenhydramine, pentachlorophenol, disopyramide, chloroquine 
diphosphate, tetracycline hydrochloride, amiodarone hydrochloride, carbamazepine, HPTE, 
pyraclostrobin, diquat dibromide, abamectin, bisphenol A, and benomyl. The VCBA currently provides 
repeated exposure simulations for caffeine, amiodarone, acetaminophen (for only HepaRG, Paini et 
al., 2016). However, in 2016 the configuration of the VCBA was improved, and presented in this work, 
now the model is able to run for any type of chemical and cell line types, in single and repeated 
exposure.  
In Figures 5-6 we report the simulation results of the VCBA for a single and repeated exposure mode 
simulation for caffeine in HepaRG cell lines, the results of the viability versus concentration in the cell, 
and concentrations in the medium, headspace and inside of the cell versus time, respectively. Figure 
7A depicts concentration – time profile curves from the PBK model built for caffeine (corresponding to 
the PBK model workflow in Figure SM1). Figure 7B, shows the PBK model simulation of viability – 
dose response for oral and dermal exposure (corresponding to the PBK model workflow in Figure 
SM2). Figure 8 shows the viability - dose response curve simulated by the IVIVE workflow as well as 
the extrapolation table from which the selected dose or viability (input) can be used to predict the 
corresponding viability or dose, respectively (corresponding to the PBK model workflow in Figure 
SM3). So far the PBK model workflows are chemical specific, and only nine (9) workflows were built, 
for the IVIVE approach only three (3) workflows were built for estragole, caffeine (Gajewska et la., 
2015), and coumarin. In the supplementary material Figure SM4 shows the overview of how the 
results, for the VCBA, are displayed in the KNIME WebPortal. These graphical representations are 
also available in table format for easy access to specific value, and a summary report can be 
downloaded in different formats (pdf, word, excel). 
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C
D 
Figure 5. VCBA Caffeine-HepaRG simulations for single exposure. A) Viability versus chemical 
concentration in the cell expressed in g/g wet weight. Concentration of caffeine in the medium (M) (B), 
headspace (M) (C) and inside of the cell (g/gww) (D) respectively versus time. The Legend reports the 
starting nominal concentrations used for simulation in M.  
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Figure 6.  VCBA simulations of HepaRG cell viability following repeated exposure to caffeine  
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A 
 B 
Figure 7 A. Concentration – time profile curves from the PBK model built for caffeine and relevant 
metabolites (corresponding to the PBK model workflow in Figure 4A). B. PBK model simulation of 
viability – dose response for oral and dermal exposure (corresponding to the PBK model workflow in 
Figure 4B). 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 
20 
 
 
Figure 8. Viability - dose response curve from IVIVE workflow, including the extrapolation table from 
which the selected dose or viability (input) versus the corresponding predicted viability or dose, 
respectively (corresponding to the PBK model workflow in Figure 5).  
  
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 
21 
 
Discussion and Conclusions 
In this study, we have illustrated step by step how the PBK models, VCBA, and the IVIVE approaches 
were implemented in KNIME. The aim of this work was to illustrate how the PBK model and VCBA, 
both biologically-based mathematical models, can be implemented in KNIME, thereby providing a 
user-friendly tool for scientists and safety assessors. The VCBA model can be used to support the 
design of in vitro experiments, e.g. the choice of test concentrations and time points for endpoint 
measurement. In the decision-making context, the VCBA can also be combined with PBK models to 
support the risk assessment of chemicals, for example by carrying out in vitro in vivo extrapolation 
(IVIVE) of no effect (safe) exposure levels (Yoon et al., 2012, 2014; Groothuis et al., 2013; Gajewska 
et al., 2015; Hamon et al., 2015; Heikkinen et al., 2013; Wetmore et al., 2015). 
The characteristics of the VCBA KNIME workflow and how it can be applied to provide a user-friendly 
graphical interface for analysis of several outcomes was illustrated, to predict time concentration 
profiles, such as intracellular concentration from the VCBA. The first generation of the KNIME VCBA 
workflow included a drop down list reporting 35 chemicals (Paini et al., 2016), for which information 
was available to perform simulations; however, the newly implemented workflow can be now run for 
any chemical, as long as the input properties are collected in a file and uploaded thus making this 
model usable for different chemicals and cell line types. We are still exploring the possibilities of 
extending the VCBA to different biological effects, which is currently able to simulate cytotoxicity 
following single or repeated exposure. The PBK models were developed for nine chemicals (see Bois 
et al., 2016) and were all implemented in KNIME. MEgen (Loizou, G, and Hogg A., 2011) a PBK 
model generator can be used to build more PBK models, which could then be exported as R files into 
KNIME workflows for ease of application. At present IVIVE workflows for extrapolation of cell viability 
to external doses are chemical-specific, and applicable to estragole, caffeine (Gajewska et la., 2015) 
and coumarin.  
The VCBA and PBK models fit into a suite of predictive computational models, which have been 
developed in the EU COSMOS project to support the safety assessment of chemicals, and in 
particular cosmetics-related substances. These tools are based solely on in vitro and in silico 
predictions thus promoting the 3Rs approaches. The biokinetic workflows are complemented by a 
range of chemistry-based workflows developed within COSMOS to support the safety assessment 
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process, with a focus on cosmetics-related substances, for which the dermal route of exposure plays 
a major role (Richarz et al., 2015a, 2015b). Within this series of computational tools developed, the 
VCBA and PBK models represent the fate of a chemical in a multi-well plate and in the body, 
respectively. The VCBA also includes a module that simulates a dynamic effect as cell toxicity in 
multiple cell lines, additionally. COSMOS KNIME prediction models have also been developed for 
specific target organ effects such as nuclear receptor binding (Steinmetz et al. 2015). Overall, PBK 
models simulate relevant time profile concentrations during absorption, distribution, metabolism and 
excretion within the body. When coupled with in vitro dynamics, PBK models can be used to relate an 
external exposure dose to intracellular concentrations and target-organ levels. The majority of 
available in vivo toxicity data are relate to oral administration. Thus models for skin permeability and 
gastrointestinal absorption contribute to the extrapolation from oral to dermal exposure.  
In the interests of transparency, extensibility and ease of use, the developed COSMOS models have 
been implemented in KNIME and made publicly available as open-source, automated tools (Richarz 
et al. 2015a, 2015b). KNIME is a flexible interface allowing users (e.g. researchers, risk assessors) to 
use these models in an easy way, integrating access to databases, data processing and analysis, as 
well as modelling approaches into flexible computational workflows. These workflows can be run on a 
desktop computer (following installation of the KNIME Analytics Platform), or simply by accessing the 
COSMOS KNIME WebPortal (http://knimewebportal.cosmostox.eu/), without the need to install any 
software locally. The WebPortal allows access to the KNIME Server and execution of workflows 
through a web interface from any recent web browser, without knowledge of the KNIME software as 
such. COSMOS Space (http://cosmosspace.cosmostox.eu/) hosts the workflow documentation and 
user guidance, including a list of all available workflows. Web tutorials for the workflows are available 
at http://www.cosmostox.eu/what/webtutorials/. The description of the PBK models and the VCBA can 
also be found in the EURL ECVAM database, the DataBase service on Alternative Methods to animal 
experimentation (DB-ALM) (Method Summary no. 162). DB-ALM is a public database service that 
provides evaluated information on development and applications of advanced and alternative 
methods to animal experimentation in biomedical sciences and (regulatory) toxicology (http://ecvam-
dbalm.jrc.ec.europa.eu/beta/). 
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In conclusion, the COSMOS biokinetic models in the COMSOS KNIME WebPortal allow for an 
intuitive step-by-step execution, but are restricted to certain pre-configured settings. The use of the 
COSMOS biokinetic model workflows in the KNIME Analytics Platform, on the other hand, gives end 
users more freedom in executing and refining the model parameters and input data according to their 
own needs. At the present time, these automated workflows cannot be used to replace the need for 
expert judgement within the risk assessment process. However, we anticipate that their use will not 
only expedite the safety assessment process, but will also ensure reproducibility and traceability in 
some of the key steps.  
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Highlights 
1. The VCBA is a mathematical model that simulates the fate of chemicals within in vitro test systems 
and their cellular effects  
2. The VCBA has been implemented in an open access web-based KNIME platform for ease of use 
3. KNIME Analytics Platform can be used to provide a user-friendly graphical interface for biokinetic 
models. 
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